Biotech Pharmaceutical Co., Ltd.

This early-stage trial tests a new drug called JH021 in 60 people with advanced solid tumors that have stopped responding to standard treatments. JH021 is a special antibody that targets two cancer-related proteins, EGFR and cMET, to potentially slow or stop tumor growth. The mai…

This study tests a new drug called JY016 in people with advanced solid tumors that have a protein called EGFR. The goal is to find a safe dose and see if the drug can shrink tumors. The trial includes people with several cancer types, such as pancreatic, lung, and colorectal canc…

This early-stage trial tests the safety of a new drug called EB070, an antibody that blocks a protein involved in allergic inflammation. Thirty-six healthy adults will receive a single injection of either EB070 or a placebo at increasing doses. The study monitors side effects and…